Answers are grounded in this paper and cite their sources.
Preclinical study demonstrates improved peripheral nerve regeneration using low-dose MnO2-loaded hydrogel conduits in rats, highlighting their anti-inflammatory and antioxidant therapeutic value.
Peripheral nerve defect repair remains a clinical challenge. Nerve guidance conduits (NGCs) are potential alternatives to autografts, but their performance can be compromised by the oxidative and inflammatory microenvironment after injury. Here, we fabricated MnO₂-loaded hydrogel NGCs at concentrations of 10, 50, and 100 μg/mL and evaluated them in a rat model of a 10-mm sciatic nerve defect. Among the three concentrations, the MnO₂@NMgel-10 (10 μg/mL) group yielded a higher sciatic functional index, denser and more orderly regenerated nerve tissue, and less gastrocnemius muscle atrophy than the hydrogel-only and higher-dose conduit groups. Early tissue analysis showed that the MnO₂@NMgel-10 group exhibited increased infiltration of CD68⁺CD206⁺ cells, upregulated expression of IL-10, and significantly downregulated expression of IL-1β, TNF-α, and 4-HNE. Furthermore, the MnO₂@NMgel-10 group showed satisfactory biosafety and biocompatibility. These findings reveal a non-monotonic concentration response and preliminarily confirm the feasibility of low-dose MnO₂-functionalized hydrogel NGCs for repairing peripheral nerve defects, providing new insights into the application of MnO₂ as a supplementary material for NGC fabrication.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: